Nearly 31% of patients said they had a worse health-related quality of life now, compared to before getting COVID-19, the researchers reported. It’s not yet clear why COVID-19 causes these lasting effects. Many viruses are capable of creating what’s known as “post-viral syndrome,” which experts describe as health problems that persist long after the infection… Read More »
Independent research experts iReach have released findings from a survey they carried out prior to the COVID-19 restrictions in Ireland. The survey, which was carried out on behalf of leading protection specialist Royal London, asked over 1,000 adults nationwide if they exercised regularly and if so, how often. 33% of respondents said they did in… Read More »
Up to 30% of patients who are seriously ill with coronavirus are developing dangerous blood clots, according to medical experts. They say the clots, also known as thrombosis, could be contributing to the number of people dying. Severe inflammation in the lungs – a natural response of the body to the virus – is behind… Read More »
TUESDAY, Jan. 28, 2020 — Before you throw any leftovers away, heed new research that suggests the choice could hit you right in your pocketbook. It turns out that almost one-third of food in American households goes to waste, costing each household thousands of dollars a year, researchers report. “Our findings are consistent with previous… Read More »
Bristol-Myers Squibb has once again come up empty-handed in one of the world’s deadliest and toughest-to-treat cancers. Thursday, the New Jersey drugmaker said adding its immuno-oncology star Opdivo to standard-of-care treatment had failed to significantly cut the risk of disease worsening or death among certain newly diagnosed glioblastoma patients. But while adding Opdivo didn’t improve on… Read More »
Dr. William Hurlbut, Paul Dabrowski and Dr. Samarth Kulkarni during a panel discussion ” Genetics, CRISPR and Medical Ethics” at the CNBC Healthy Returns conference in New York on May 21, 2019. Astrid Stawiarz | CNBC After a Chinese scientist last year made history by using CRISPR technology to genetically modify two newborns, the scientific… Read More »
LONDON – 9th April 2019 – OutSystems, provider of the number one platform for low-code rapid application development, today announced that it has been named a 2019 Top Rated Low-Code Platform by TrustRadius, the most trusted site for business technology B2B software reviews. This distinction, based entirely on the feedback and rating from end users,… Read More »